Larry W. Greer

Greer Capital Advisors LLC (GCA) is a private equity/venture capital firm founded in 2002 by Lawrence W. Greer. The firm is headquartered in Mountain Brook, Alabama.

Aetos Technologies, Inc. is a technology development company. The firm offers funding and management services to commercialize and market technologies developed at research institutions. The company services include evaluation, product, process development, business management, and financing. Aetos Technologies was founded in 2003 and is headquartered in Auburn, AL.

Vivo Biosciences, Inc. develops platform for preclinical research, drug discovery and therapeutics. Its products include ready to use HuBiogel, angio-start assay kit, custom products, and mini-tumor assay plates. It also offers pre-clinical drug testing services, efficient 3D bioassay platform, and other HuBiogel applications. The company was founded by Lawrence J. DeLucas and Raj K. Singh in 2004 and is headquartered in Birmingham, AL.

Part of DURECT Corp., Southern BioSystems, Inc. is a company that manufactures and develops biodegradable polymer and non-polymer drug delivery systems. The company is based in Birmingham, AL. The company was founded by Alan H. Dean. Southern BioSystems was acquired by DURECT Corp. on April 30, 2001 for $13.64 million.

Dunn Investment Co., Inc. is a private company that specializes in asphalt and aggregates. Dunn Construction has five plants located in the greater Birmingham and surrounding areas, offering a wide variety of asphalt products suited for any need or application. The company is based in Birmingham, AL and has subsidiaries in the United States. The company has a vertically integrated approach to asphalt production and paving, as well as their own aggregate operation. The company has five paving crews, one milling crew, and three base crews, which allows them to carry out jobs of any size. The company also prioritizes community service and giving back to their community.

PNP Therapeutics, Inc. operates as a biopharmaceutical company which develops a platform technology and proprietary products for the treatment of cancer. It offers E. coli purine nucleoside phosphorylase that work with nucleoside prodrugs generating active metabolites with anti-tumor activity. The company was founded by William B. Parker and Eric J. Sorscher and is headquartered in Birmingham, AL.

DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.